Skip to main content
Account

Peer review reports

From: Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach

Original Submission
18 Jul 2023 Submitted Original manuscript
27 Oct 2023 Reviewed Reviewer Report - Matthew Walton
6 Jan 2024 Reviewed Reviewer Report
11 Jan 2024 Author responded Author comments - Ash Bullement
25 Jan 2024 Reviewed Reviewer Report - Matthew Walton
Resubmission - Version 2
11 Jan 2024 Submitted Manuscript version 2
Publishing
19 Apr 2024 Editorially accepted
22 Jul 2024 Article published 10.1186/s12885-024-12287-6

Learn about peer review

Back to article page

Navigation